Loss of heterozygosity studies in extracranial metastatic meningiomas

Journal of Neuro-Oncology

Volumn 85, Issue 1, 2007, Pages 81-85

  Gladin, Caroline Regna ^a   Salsano, Ettore ^a   Menghi, Francesca ^a   Grisoli, Marina ^a   Ghielmetti, Francesco ^a   Milanesi, Ida ^a   Pollo, Bianca ^a   Brock, Stefano ^a   Cusin, Alberto ^a   Minati, Ludovico ^a   Finocchiaro, Gaetano ^a   Bruzzone, Maria Grazia ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Loss of heterozygosity; Meningioma; Metastasis

Indexed keywords

ADULT; ARTICLE; BONE METASTASIS; CANCER GRADING; CASE REPORT; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME 9P; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; DNA EXTRACTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MALE; MENINGIOMA; RECURRENT CANCER; THORAX RADIOGRAPHY;

ADULT; BONE NEOPLASMS; BRAIN; CHROMOSOMES; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MENINGIOMA; MIDDLE AGED; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548801465     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9386-3     Document Type: Article

References (21)

1. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088-1095 discussion 1088-1095
2. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225 discussion 226-219
3. Enam SA, Abdulrauf S, Mehta B, Malik GM, Mahmood A (1996) Metastasis in meningioma. Acta Neurochir (Wien) 138:1172-1177 discussion 1177-1178
4. Delgado-Lopez PD, Martin-Velasco V, Castilla-Diez JM, Fernandez-Arconada O, Corrales-Garcia EM, Galacho-Harnero A, Rodriguez-Salazar A, Perez-Mies B (2006) Metastatic meningioma to the eleventh dorsal vertebral body: Total en bloc spondylectomy. Case report and review of the literature. Neurocirugia (Astur) 17:240-249
5. Chamberlain MC, Glantz MJ (2005) Cerebrospinal fluid-disseminated meningioma. Cancer 103:1427-1430
6. Cai DX, Banerjee R, Scheithauer BW, Lohse CM, Kleinschmidt-Demasters BK, Perry A (2001) Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: Diagnostic and prognostic implications. J Neuropathol Exp Neurol 60:628-636
7. Cerda-Nicolas M, Lopez-Gines C, Perez-Bacete M, Roldan P, Talamantes F, Barbera J (2003) Histologically benign metastatic meningioma: morphological and cytogenetic study. Case report. J Neurosurg 98:194-198
8. Lamszus K, Kluwe L, Matschke J, Meissner H, Laas R, Westphal M (1999) Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogen 110:103-110
9. Lee JY, Finkelstein S, Hamilton RL, Rekha R, King JT Jr., Omalu B (2004) Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery 55:1163-1173
10. Mihaila D, Gutierrez JA, Rosenblum ML, Newsham IF, Bogler O, Rempel SA (2003) Meningiomas: Analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Clin Cancer Res 9:4435-4442
11. Perry A, Banerjee R, Lohse CM, Kleinschmidt-DeMasters BK, Scheithauer BW (2002) A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol 12:183-190
12. Kim YJ, Ketter R, Henn W, Zang KD, Steudel WI, Feiden W (2006) Histopathologic indicators of recurrence in meningiomas: Correlation with clinical and genetic parameters. Virchows Arch 449:529-538
13. D'Aiuto M, Veronesi G, Pelosi G, Presicci PF, Ferraroli GM, Gasparri R, Spaggiari L (2005) Two-year survival after multiple bilateral lung metastasectomies for cranial meningioma. Ann Thorac Surg 80:1129-1130
14. Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045-1054
15. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M (2004) Malignant progression in meningioma: Documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210-218
16. Schiffer D, Ghimenti C, Fiano V (2005) Absence of histological signs of tumor progression in recurrences of completely resected meningiomas. J Neurooncol 73:125-130
17. Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94:14719-14724
18. van Tilborg AA, Al Allak B, Velthuizen SC, de Vries A, Kros JM, Avezaat CJ, de Klein A, Beverloo HB, Zwarthoff EC (2005) Chromosomal instability in meningiomas. J Neuropathol Exp Neurol 64:312-322
19. Ruttledge MH, Xie YG, Han FY, Peyrard M, Collins VP, Nordenskjold M, Dumanski JP (1994) Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes Cancer 10:122-130
20. Bostrom J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661-669
21. Figueroa BE, Quint DJ, McKeever PE, Chandler WF (1999) Extracranial metastatic meningioma. Br J Radiol 72:513-516